Skip to main content
    P

    PureTech Health PLC (PRTC)

    Official site

    BIOTECHNOLOGY

    $17.42
    +0.00 (+0.00%)

    Last updated: Nov 06, 2026 at 4:00 PM ET

    PureTech Health PLC (PRTC) Financials: Revenue, Profit and Cash Flow

    Updated Apr 29, 2026. Financial statements from company filings, amounts in US dollars.

    PureTech Health reported revenue of $4.66M for the fiscal year ended Dec 31, 2025, down 3.5% from the year before. That year, net income was -$109.74M with a net margin of -2355.4%, operating cash flow was -$85.33M and free cash flow was -$85.34M. The quarter ended Mar 31, 2026 had revenue of $2.80M and net income of -$64.89M.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue grew from $4.43M, a compound annual rate of 0.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$4.66M-3.5%100.0%-2114.7%-2355.4%
    Dec 2024$4.83M+45.0%26.0%-2818.9%1108.3%
    Dec 2023$3.33M+59.3%-48.1%-4390.4%-1972.9%
    Dec 2022$2.09M-79.1%-6546.2%-9464.4%-2409.3%
    Dec 2021$9.98M+19.6%-1007.0%-1506.0%-606.9%
    Dec 2020$8.34M-4.0%100.0%-1433.1%71.8%
    Dec 2019$8.69M-46.9%-888.1%-1558.5%4847.4%
    Dec 2018$16.37M+2418.6%-372.8%-635.4%-266.7%
    Dec 2017$650.00K-85.3%-10828.5%-17756.9%4749.1%
    Dec 2016$4.43MN/A64.6%-1668.4%-1101.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Mar 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$4.66M$4.83M$3.33M$2.09M$9.98M$8.34M$8.69M$16.37M$650.00K$4.43M
    Cost of revenue$0$3.57M$4.93M$152.43M$110.47M$0$85.85M$77.40M$71.03M$1.57M
    Gross profit$4.66M$1.26M-$1.60M-$136.81M-$100.49M$8.34M-$77.16M-$61.03M-$70.39M$2.86M
    Research and development$45.74M$54.28M$96.23M$116.11M$81.52M$61.19M$65.17M$57.29M$71.67M$41.20M
    Operating income-$98.53M-$136.09M-$146.20M-$197.81M-$150.28M-$119.53M-$135.40M-$104.02M-$115.42M-$73.93M
    Net income-$109.74M$53.51M-$65.70M-$50.35M-$60.56M$5.99M$421.14M-$43.65M$30.87M-$48.79M
    EBITDA-$61.80M$37.38M-$11.63M-$188.91M$26.70M$62.69M$487.78M-$65.27M-$40.79MN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Jun 2025Mar 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$2.80M$2.80M$1.85M$4.03M$4.03M$288.00K$178.57K$178.57K$90.00K$3.15M$9.01M$9.01M
    Gross profit$1.15M$1.15M-$23.05M$42.95M$42.95M-$38.64M-$1.68M-$1.68M-$21.45M$89.00K-$24.92M-$24.92M
    Operating income-$50.40M-$50.40M-$47.93M-$69.70M-$69.70M-$66.40M-$69.48M-$69.48M-$35.02M-$76.16M-$101.34M-$101.34M
    Net income-$64.89M-$64.89M-$44.60M$95.28M$95.28M-$41.77M-$40.37M-$40.37M-$20.35M-$25.00M-$23.09M-$23.09M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $4.92M by $249.15M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$534.71M$602.63M$693.97M$702.65M$946.01M$989.99M$941.18M$441.76M$339.85M$298.75M
    Current assets$305.02M$386.26M$347.20M$386.19M$501.81M$414.35M$168.84M$259.79M$198.11M$288.15M
    Cash and equivalents$254.07M$280.64M$191.08M$149.87M$465.71M$403.88M$132.36M$117.05M$72.65M$62.96M
    Total liabilities$229.03M$194.70M$235.74M$155.06M$361.86M$336.45M$290.78M$274.79M$275.85M$206.34M
    Short-term debt$4.92M$4.11M$3.70M$7.50M$5.50M$26.45M$1.46M$12.01M-$121.56M-$81.43M
    Long-term debt$0$0$0$10.24M$14.26M$14.82M$0$357.00KN/AN/A
    Shareholder equity$312.07M$414.71M$464.07M$542.22M$593.51M$669.75M$668.04M$275.51M$214.30M$177.67M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Jun 2025Mar 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$534.71M$534.71M$553.24M$602.63M$602.63M$579.95M$693.97M$693.97M$693.97M$693.55M$702.65M$702.65M
    Total liabilities$229.03M$229.03M$184.22M$194.70M$194.70M$273.74M$235.74M$235.74M$235.74M$184.66M$155.06M$155.06M
    Cash and equivalents$254.07M$254.07M$262.25M$280.64M$280.64M$308.48M$191.08M$191.08M$191.08M$350.51M$149.87M$149.87M
    Shareholder equity$312.07M$312.07M$375.98M$414.71M$414.71M$315.87M$464.07M$464.07M$464.07M$513.67M$542.22M$542.22M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$85.33M-$134.37M-$105.92M-$178.79M-$158.27M-$131.83M-$98.16M-$72.80M-$88.69M-$58.03M
    Capital expenditures$6.01K$11.00K$245.00K$2.18M$5.66M$5.42M$12.54M$4.49M$2.17M$3.68M
    Free cash flow-$85.34M-$134.38M-$106.16M-$180.97M-$163.94M-$137.25M-$110.69M-$77.29M-$90.86M-$61.71M
    Dividends paid$0$0$0$0$0$0$112.00K$8.00K$91.00KN/A
    Share repurchases$2.06M$107.56M$19.65M$26.49M$13.33M$0$1.28M$35.00KN/AN/A
    Investing cash flow$63.44M$240.89M$68.99M-$107.22M$197.38M$364.48M$63.66M-$39.65M$83.68M-$43.23M
    Financing cash flow-$6.34M-$16.96M$78.14M-$29.83M$22.73M$38.87M$49.91M$156.89M$14.70M$29.49M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Jun 2025Mar 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$38.47M-$38.47M-$46.34M-$53.00M-$54.35M-$80.01M-$39.94M-$39.94M-$20.39M-$65.13M-$100.30M-$100.30M
    Capital expenditures$5.98K$5.98K$3$11.00K$11.00K$4$173.05K$173.05K$0$70.00K$635.53K$635.53K
    Free cash flow-$38.48M-$38.48M-$46.34M-$53.01M-$54.37M-$80.01M-$40.12M-$40.12M-$20.39M-$65.20M-$100.93M-$100.93M
    Last 12 quarters

    Frequently Asked Questions About PRTC

    What is PureTech Health's annual revenue?

    PureTech Health reported revenue of $4.66M for the fiscal year ended Dec 31, 2025.

    How fast is PureTech Health's revenue growing?

    Revenue was down 3.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 30.6%.

    Is PureTech Health profitable?

    No. PureTech Health reported net income of -$109.74M for the fiscal year ended Dec 31, 2025, with a net margin of -2355.4%.

    How much free cash flow does PRTC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$85.33M minus capital expenditures of $6.01K produced free cash flow of -$85.34M.

    How much debt does PureTech Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $4.92M and cash and equivalents of $254.07M.